BioSig (BSGM) Achieves a Major Milestone with Its First Commercial Sale of Three PURE EP™ Systems.
Three Reports Over 215% in Bookable Gains to Cap off 2020 for our Members, New Report on Deck
2020 was an amazing year for our group! Well over 2500% in realistic bookable gains. We will be kicking off 2021 with our first feature report Tuesda...
The Future of Biotech is mRNA (Messenger RNA)
The successful use of mRNA in the development of the covid-19 vaccines will likely spur further investment and development toward treatments for other...
U.S. Gold (USAU) Positive Results from Drilling Program at the CK Gold Project
US Gold's new president stated “With the drilling from 2017, 2018, and now 2020, we anticipate expanding the resource.”
Genprex (NASDAQ: GNPX) Completes Another Milestone
We believe GNPX has just gotten started. Their ONCOPREX delivery system and the REQORSA technology are proprietary and no one else has anything like i...
These “Tiny Bubbles” from Genprex (GNPX) Could Beat Cancer
The FDA granted Fast Track Designation for REQORSA in combination with AstraZeneca’s Tagrisso for the treatment of non-small cell lung cancer.
Over 71% in Bookable Gains on our “Disruptive Tech” 12-15-20 Report Vuzix (NASDAQ: VUZI) New Report Coming Monday 12-21-20 at Market Open
Vuzix (NASDAQ: VUZI) had a strong week following our coverage Tuesday morning. New report coming Monday at market open.
Disruptive Technology Report, Broad Based Adoption of Smart Glasses
"Smart Glasses Are Our Reality. As the Augmented Reality (AR) markets continue to grow, smart glasses may soon be everywhere."
Report Updates, Current Profit Opportunities (NASDAQ: FUV), (NASDAQ: SGMA), (NASDAQ: ELYS), (NYSE: ATNM) and (NASDAQ: WWR)
We have four recent small cap stock alerts offering up profit opportunities today and one that had great early gains, but now everyone's asking "what'...
Citius Pharma Starting to Trend as Word of Positive Pipeline Progress Hits the Street
CTXR has a worldwide license to develop Mino-Lok from the MD Anderson Cancer Center. It is a proprietary blend of three FDA approved compounds.